MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12185-017-2378-y

Медицинская библиотека · International journal of hematology · 2017

Successful treatment of follicular lymphoma with second-generation tyrosine kinase inhibitors administered for coexisting chronic myeloid leukemia.

Fujiwara Shin-Ichiro, Shirato Yuya, Ikeda Takashi, Kawaguchi Shin-Ichiro, Toda Yumiko, Ito Shoko, Ochi Shin-Ichi, Nagayama Takashi, Mashima Kiyomi, Umino Kento, Minakata Daisuke, Nakano Hirofumi, Morita Kaoru, Yamasaki Ryoko, Kawasaki Yasufumi, Sugimoto Miyuki, Ashizawa Masahiro, Yamamoto Chihiro, Hatano Kaoru, Sato Kazuya, Oh Iekuni, Ohmine Ken, Muroi Kazuo, Kanda Yoshinobu

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

Tyrosine kinase inhibitors (TKIs) are standard therapy for chronic myeloid leukemia (CML). However, the effects of these agents on mature B cell lymphoma are not well known. We describe a 50-year-old man who was diagnosed with CML in the chronic phase and treated with imatinib. After 3 years of imatinib therapy that achieved a complete cytogenetic response of CML, he developed Philadelphia-negative follicular lymphoma (FL). Rituximab monotherapy induced a partial response of FL, and he subsequently achieved a major molecular response (MMR) of CML. Three years later, however, the MMR was lost, followed by the progression of FL. Imatinib was switched to nilotinib for the treatment of CML, while we chose watchful waiting for FL. He achieved MMR again under treatment with nilotinib for 8 months including one month of substitutional use of dasatinib due to adverse events, but thereafter nilotinib was switched to bosutinib due to hyperbilirubinemia. With the administration of second-generation TKIs (2G-TKIs) for a total of 18 months, he achieved a complete response to FL without antilymphoma treatment. This is the first report to suggest that 2G-TKIs may have direct or indirect effects on FL.

Для цитирования: Fujiwara Shin-Ichiro, Shirato Yuya, Ikeda Takashi, Kawaguchi Shin-Ichiro, Toda Yumiko, Ito Shoko, Ochi Shin-Ichi, Nagayama Takashi, Mashima Kiyomi, Umino Kento, Minakata Daisuke, Nakano Hirofumi, Morita Kaoru, Yamasaki Ryoko, Kawasaki Yasufumi, Sugimoto Miyuki, Ashizawa Masahiro, Yamamoto Chihiro, Hatano Kaoru, Sato Kazuya, Oh Iekuni, Ohmine Ken, Muroi Kazuo, Kanda Yoshinobu. Successful treatment of follicular lymphoma with second-generation tyrosine kinase inhibitors administered for coexisting chronic myeloid leukemia.. International journal of hematology. 2017. DOI: 10.1007/s12185-017-2378-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.